Evelo Biosciences Inc (EVLO) PT Lowered to $5 at Chardan Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts EVLO Hot Sheet
Price: $0.00 --0%
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 35
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 35
Join SI Premium – FREE
Chardan Capital Markets analyst Keay Nakae lowered the price target on Evelo Biosciences Inc (NASDAQ: EVLO) to $5.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- ServiceNow (NOW) PT Raised to $160 at Stifel
- Ambiq Micro Inc (AMBQ) PT Raised to $85 at Stifel
- DTE Energy (DTE) PT Raised to $134 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
